BBVA remedies in takeover bid are insufficient, Sabadell's CEO says
1. Sabadell's CEO criticized BBVA's remedies for competition concerns in its takeover bid.
FAQ
Why Bearish?
Sabadell's concerns may hinder BBVA's takeover progress, negatively affecting investor sentiment.
How important is it?
The criticism from a competitor affects perceived viability of BBVA's acquisition strategy.
Why Short Term?
Immediate issues over the takeover could impact BBVA's stock price quickly.